The development of secondary mitral regurgitation (MR) due to left ventricular dysfunction, also known as functional MR, is strongly associated with a poor prognosis in patients with heart failure. The mechanisms underlying secondary MR are multifactorial; accurate imaging assessment of secondary MR may be challenging and nuanced; and the appropriate roles of medical, surgical, and interventional therapies for management of secondary MR are controversial and evolving.
M itral regurgitation (MR) is among the most common valvular heart disorders, with an estimated prevalence in the United States of w1.7%, increasing with age to w9.3% in those >75 years of age (1) . MR is classified as primary (also known as organic) when principally due to a structural or degenerative abnormality of the mitral valve (MV), whether of the leaflets, chordae tendineae, papillary muscles, or mitral annulus. Secondary (also known as functional) MR occurs in the absence of organic MV disease, usually from left ventricular (LV) dysfunction. It is more common than primary MR (2) , is associated with a worse prognosis (com- response that minimizes the degree of regurgitation; insufficient leaflet remodeling may contribute to severe MR (5, 6) . However, even in patients with increased mitral leaflet area, papillary muscle displacement with subsequent decreased coaptation length may still result in significant MR (6) .
The normal saddle-shape of the annulus is important for maintaining normal leaflet stress (7) . Loss of this shape and annular flattening with LV remodeling result in increased leaflet stress with secondary MR. In addition, LV systolic dysfunction reduces the strength of MV closing, which opposes the leaflet tethering forces created by papillary muscle displacement. These pathological changes culminate in failure of leaflet coaptation and decreased valvular closing forces due to LV dysfunction, resulting in MR. The Carpentier classification, commonly used by surgeons to describe MV pathology, categorizes MR using a mechanistic and functional approach to the mitral leaflets (8) . Secondary MR is most commonly Carpentier type IIIB, and occasionally type I. ISCHEMIC VERSUS NONISCHEMIC MR. MR can be further classified as either ischemic or nonischemic.
In ischemic MR (the more frequent etiology), LV remodeling after myocardial infarction (MI) results in papillary muscle displacement, causing systolic tenting of the MV. Global left ventricular ejection fraction (LVEF) does not have to be reduced; regional wall motion abnormalities with remodeling may result in sufficient MV tethering to cause severe MR, despite preserved LVEF (9) . Symmetric or asymmetric leaflet tethering may occur. Symmetric tethering is associated with substantial systolic dysfunction, global remodeling, and increased LV sphericity with a central regurgitant jet. Asymmetric tethering most frequently results from localized remodeling affecting the posterior papillary muscle, with posterior tenting of both leaflets (most pronounced at the medial or P3 portion of the posterior leaflet) causing a posteriorly directed asymmetric regurgitant jet (Carpentier Type IIIB) (10) . Mitral annular dilation typically occurs late in the pathophysiology of secondary MR, and is often asymmetric, with greater involvement of the posterior annulus (11) . Papillary muscle infarction is rarely the cause of secondary MR (12) .
Nonischemic MR, most commonly due to longstanding hypertension or idiopathic dilated cardiomyopathy, is characterized by global LV dilation with increased sphericity and (typically) a centrally located regurgitant jet. Symmetric mitral annular dilation is greatest in the septal-lateral direction, and correlates with the severity of LV dysfunction (13) .
MR DUE TO ATRIAL FIBRILLATION. An additional, although relatively infrequent, cause of severe secondary MR is isolated LA enlargement, with or without atrial fibrillation, resulting in a dilated mitral annulus and reduced leaflet coaptation (without tenting or prolapse), with normal LV function and mitral leaflets (Carpentier Type I) (14) . In patients with atrial fibrillation, improvement in MR severity may occur with restoration of sinus rhythm, suggesting a causal relationship (14) . Conventional 2-dimensional (2D) assessment for MR quantification relies on measurement of the MR jet core at its vena contracta or proximal convergence zone using methods that assume circular orifice geometry. MR severity may, therefore, be significantly underestimated when the orifice is elliptical (as is typical in secondary MR) (4), a situation that is compounded if multiple jets are present. Threedimensional (3D) echocardiography overcomes this limitation by permitting direct planimetry of the vena contracta, regardless of orifice shape or number of jets (21) . Conversely, both 2D and 3D color flow Doppler tend to overestimate the orifice area because of their inability to resolve the high velocity jet core due to aliasing and blooming artifacts. Secondary MR severity also varies during the cardiac cycle, and can peak in early or late systole, further complicating evaluation, which is traditionally done in midsystole.
PROGNOSTIC IMPLICATIONS OF SECONDARY MR
No single parameter is sufficient to quantify the degree of MR, and multimodality assessment using both 2D and 3D echocardiography is optimal (22) .
Although somewhat controversial, outcomes studies suggest that lesser absolute quantitative degrees of regurgitation in secondary MR may have the same or greater effect on mortality than in The diagram illustrates the valve and supporting structures. (25) . Exercise results in greater pre-load and afterload, a more spherical ventricle, increased coaptation distance, and systolic expansion of the mitral annulus. Such changes can occur in the absence of ischemia (26) and may result in acute pulmonary edema (27) . Exercise-induced severe MR may identify patients at heightened risk for death or HF hospitalization (28) . Quantitatively, an exerciseinduced EROA increase of $13 mm 2 has been associated with increased morbidity and mortality, although measuring EROA during or immediately after exercise is technically challenging due to tachycardia and tachypnea (29) . Exercise echocardiography may also demonstrate increasing pulmonary artery pressures and lack of LV contractile reserve, findings associated with LV dysfunction and poor prognosis after MV surgery (30, 31) . Exercise may also induce greater LV dyssynchrony with increased MR, which might improve with cardiac resynchronization therapy (CRT) (see later discussion). However, the predictive value of exercise echocardiography is Cardiac magnetic resonance (CMR) imaging and Finally, in patients with severe HF and secondary MR refractory to standard therapies, consideration should be given to mechanical LV assist devices and heart transplantation.
MEDICAL THERAPY FOR SECONDARY MR
GDMT for HF is first-line treatment for patients with secondary MR (19) , although the morbidity and mortality of patients with LV dysfunction and secondary MR remain high. Among 404 secondary MR patients treated with GDMT, 4-year cardiac mortality occurred in 43% and 45% with moderate and severe MR, respectively, compared with only 6% with mild MR (p ¼ 0.003) (37) . Moderate or severe MR was also an independent predictor of new onset HF in patients (19) . Table 1 . (Figure 4) . The CorCap is a passive external LV mesh restraint intended to reduce wall stress (62) .
Abbreviations as in
In the 300-patient randomized ACORN trial, the Cor- Optimal management of concomitant secondary MR in patients undergoing CABG is still uncertain.
There is general agreement that severe MR should be addressed at the time of CABG, because coronary revascularization alone will only occasionally ameliorate MR (77, 78) . In the RIME (Randomised Ischaemic Mitral Evaluation) trial, 73 patients with moderate secondary MR were randomized to CABG plus MV annuloplasty versus CABG alone (79) .
MV repair prolonged the duration of aortic crossclamping, cardiopulmonary bypass, intubation, and hospitalization, and led to more blood transfusions, although operative mortality was 3% in both groups.
At 1 year, MV annuloplasty resulted in improved peak oxygen consumption during exercise (the primary endpoint), LV remodeling, and reduced MR severity (80) . 
